Analystreport

BioXcel Therapeutics (NASDAQ:BTAI) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report